research use only

Ibrutinib (PCI-32765) Btk inhibitor

Cat.No.S2680

Ibrutinib is a potent and highly selective Brutons tyrosine kinase (Btk) inhibitor with IC50 of 0.5 nM in cell-free assays, modestly potent to Bmx, CSK, FGR, BRK, HCK, less potent to EGFR, Yes, ErbB2, JAK3, etc. Ibrutinib is applicable as a Btk ligand in the synthesis of a series of PROTACs including P13I.
Jump to

Quality Control

Batch: Purity: 99.98%
99.98
Selleck AI:Q&A of Ibrutinib (PCI-32765): Insights Rooted in Extensive Publications, Every Answer Cited
AI will take about 1 minute to answer this question... 0%

Solubility in DMSO or Water

In vitro
Batch:

DMSO : 88 mg/mL (199.77 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Ethanol : 8 mg/mL

Water : Insoluble

The solubility data above are all experimental results (not literature values).

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Read more about Ibrutinib (PCI-32765) solubility in DMSO or water

Working Concentrations for Cell Culture Treatment

Search directly for a cell line, or select a cell line to find matched working concentrations

Read more about Ibrutinib (PCI-32765) working concentrations for cell culture treatment

×

Mechanism of Action

Information Ibrutinib (PCI-32765) is a potent, irreversible covalent BTK inhibitor. It affects BCR and NF-κB signaling pathways by covalently binding to Cys-481 of BTK, effectively inhibiting tumor cell proliferation and inducing apoptosis.

Read more about Ibrutinib (PCI-32765) IC50 for cell-based and cell-free assays

Primary Applications and Mechanism of Action

Read more about Ibrutinib (PCI-32765) Mechanism of Action

Chemical Information, Storage & Stability

Molecular Weight 440.5 Formula

C25H24N6O2

Storage (From the date of receipt)
CAS No. 936563-96-1 Download SDF Storage of Stock Solutions

Synonyms PCI-32765 Smiles C=CC(=O)N1CCCC(C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N

Read more about storage & stability

Please select the combination compounds (Multiple selections allowed)
Please select a combination compound first

Read more comparative analysis about Ibrutinib (PCI-32765)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Frequently Asked Questions

Question 1:
How to reconstitute it for in vivo studies?

Answer:
For in vivo study, we suggest to use 5% DMSO+30% PEG 300+5% Tween 80+ddH2O up to 10mg/ml for it.